Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 USD | -0.14% | -1.57% | +15.61% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 6.69B | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Earnings Flash (BPMC) BLUEPRINT MEDICINES CORPORATION Reports Q3 Revenue $56.6M, vs. Street Est of $50.7M